Pure erythroid leukemia: A reassessment of the entity using the 2008 World Health Organization classification

Modern Pathology

Volumn 24, Issue 3, 2011, Pages 375-383

  Liu, Wei ^a   Hasserjian, Robert P ^b   Hu, Ying ^a   Zhang, Liping ^c   Miranda, Roberto N ^a   Medeiros, L Jeffrey ^a   Wang, Sa A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

acute erythroleukemia; cytogenetics; erythroid predominance; myelodysplastic syndromes; pure erythroid leukemia; survival

Indexed keywords

ANTINEOPLASTIC AGENT; UVOMORULIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CELL MATURATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLASSIFICATION ALGORITHM; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROID CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPE; LEUKEMIA; MALE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PURE ERYTHROID LEUKEMIA; RETROSPECTIVE STUDY; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BONE MARROW CELLS; CELL PROLIFERATION; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; DIAGNOSIS, DIFFERENTIAL; ERYTHROBLASTS; FEMALE; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PHENOTYPE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TERMINOLOGY AS TOPIC; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 79952188945     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.194     Document Type: Article

References (27)

1. Di Guglielmo G. Le Malattie Eritremiche ed Eritroleu-cemiche. Il Pensiero Scientifico: Rome, 1962.
2. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103: 620-625.
3. Hasserjian RP, Howard J, Wood A, et al. Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6. J Clin Pathol 2001;54:205-209. (Pubitemid 32205041)
4. Kowal-Vern A, Mazzella FM, Cotelingam JD, et al. Diagnosis and characterization of acute erythroleuke-mia subsets by determining the percentages of myelo-blasts and proerythroblasts in 69 cases. Am J Hematol 2000;65:5-13.
5. Garand R, Duchayne E, Blanchard D, et al. Minimally differentiated erythroleukaemia (AML M6 'variant'): a rare subset of AML distinct from AML M6. Groupe Francais d'Hematologie Cellulaire. Br J Haematol 1995; 90:868-875.
6. Kowal-Vern A, Cotelingam J, Schumacher HR. The prognostic significance of proerythroblasts in acute erythroleukemia. Am J Clin Pathol 1992;98:34-40.
7. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17: 3835-3849.
8. Arber DA, Orazi A, Porwit A, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC press, 2008.
9. Sadahira Y, Kanzaki A, Wada H, et al. Immunohisto-chemical identification of erythroid precursors in paraffin embedded bone marrow sections: spectrin is a superior marker to glycophorin. J Clin Pathol 1999; 52:919-921. (Pubitemid 30005367)
10. Armeanu S, Buhring HJ, Reuss-Borst M, et al. E-cadherin is functionally involved in the maturation of the erythroid lineage. J Cell Biol 1995;131:243-249.
11. Armeanu S, CA MU, Klein G. Involvement of E-cadherin in the development of erythroid cells; subject heading. Hematology 2000;5:307-316. (Pubitemid 32208473)
12. Buhring HJ, Muller T, Herbst R, et al. The adhesion molecule E-cadherin and a surface antigen recognized by the antibody 9C4 are selectively expressed on erythroid cells of defined maturational stages. Leukemia 1996;10:106-116. (Pubitemid 26052988)
13. Hasserjian RP, Zuo Z, Garcia C, et al. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. Blood 2010;115:1985-1992.
14. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998;92: 2322-2333. (Pubitemid 28452973)
15. Mazzella FM, Alvares C, Kowal-Vern A, et al. The acute erythroleukemias. Clin Lab Med 2000;20:119-137. (Pubitemid 30111895)
16. Mazzella FM, Kowal-Vern A, Shrit MA, et al. Acute erythroleukemia: evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis. Am J Clin Pathol 1998;110:590-598. (Pubitemid 28491963)
17. Domingo-Claros A, Larriba I, Rozman M, et al. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Haematologica 2002;87:148-153. (Pubitemid 34160621)
18. Wang SA, Tang G, Fadare O, et al. Erythroid-predomi-nant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification. Mod Pathol 2008;21:1394-1402.
19. Goldberg SL, Noel P, Klumpp TR, et al. The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease. Am J Clin Oncol 1998;21:42-47. (Pubitemid 28092971)
20. Park S, Picard F, Dreyfus F. Erythroleukemia: a need for a new definition. Leukemia 2002;16:1399-1401.
21. Acquaviva C, Gelsi-Boyer V, Birnbaum D. Myelodys-plastic syndromes: lost between two states? Leukemia 2010;24:1-5.
22. Olopade OI, Thangavelu M, Larson RA, et al. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood 1992;80:2873-2882.
23. Honda Y, Manabe A, Tsuchida M, et al. Clinicopatho-logical characteristics of erythroblast-rich RAEB and AML M6a in children. Int J Hematol 2008;88:524-529.
24. Oki Y, Kantarjian HM, Zhou X, et al. Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center. Blood 2006; 107:880-884. (Pubitemid 43156282)
25. Villeval JL, Le Van Kim C, Bettaieb A, et al. Early expression of glycophorin C during normal and leukemic human erythroid differentiation. Cancer Res 1989;49:2626-2632. (Pubitemid 19143389)
26. Solary E, Casasnovas RO, Campos L, et al. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR-pheno-types with shorter survival. Groupe d'Etude Immuno-logique des Leucemies (GEIL). Leukemia 1992; 6:393-399.
27. Southcott MJ, Tanner MJ, Anstee DJ. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999;93:4425-4435. (Pubitemid 29279286)